Icosavax Inc. (ICVX) NASDAQ
$15.31 (0.14) (-0.91%)
Market Cap: -
As of 02/16/24 04:00 PM EST. Market closed.
Icosavax Inc. (ICVX)
NASDAQ
$15.31
(0.14) (-0.91%)
Market Cap: -
As of 02/16/24 04:00 PM EST. Market closed.
icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. the company was founded on breakthrough computationally-designed virus like particle technology, exclusively licensed for a variety of infectious disease indications from the institute for protein design at the university of washington. ... read more
icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. the company was founded on breakthrough computationally-designed virus like particle technology, exclusively licensed for a variety of infectious disease indications from the institute for protein design at the university of washington. icosavax is located in seattle. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Simpson Adam K. | Chief Executive Officer | Feb 01, 2024 | Option Exercise | $1.04 | 15,000 | 15,600 | 373,657 | Feb 02, 2024, 07:03 PM |
Simpson Adam K. | Chief Executive Officer | Feb 01, 2024 | Sale | $15.29 | 15,000 | 229,386 | 358,657 | Feb 02, 2024, 07:03 PM |
Simpson Adam K. | Chief Executive Officer | Jan 22, 2024 | Option Exercise | $1.03 | 98,016 | 100,979 | 358,657 | Jan 23, 2024, 06:15 PM |
Kanesa-thasan Niranjan | Chief Medical Officer | Jan 04, 2023 | Option Exercise | $2.34 | 106,373 | 249,298 | 330,353 | Jan 05, 2024, 07:18 PM |
Kanesa-thasan Niranjan | Chief Medical Officer | Jan 04, 2023 | Sale | $15.70 | 106,373 | 1,670,460 | 223,980 | Jan 05, 2024, 07:18 PM |
Simpson Adam K. | Chief Executive Officer | Jan 02, 2024 | Option Exercise | $1.04 | 15,000 | 15,600 | 275,641 | Jan 04, 2024, 05:05 PM |
Simpson Adam K. | Chief Executive Officer | Jan 02, 2024 | Sale | $15.67 | 15,000 | 235,087 | 260,641 | Jan 04, 2024, 05:05 PM |
Simpson Adam K. | Chief Executive Officer | Dec 21, 2023 | Option Exercise | $1.36 | 165,917 | 225,085 | 350,641 | Dec 22, 2023, 06:27 PM |
Simpson Adam K. | Chief Executive Officer | Dec 21, 2023 | Sale | $15.44 | 90,000 | 1,389,280 | 300,641 | Dec 22, 2023, 06:27 PM |
Simpson Adam K. | Chief Executive Officer | Dec 20, 2023 | Sale | $15.46 | 62,205 | 961,509 | 184,724 | Dec 22, 2023, 06:27 PM |
Russo Thomas Joseph | Chief Financial Officer | Dec 20, 2023 | Sale | $15.46 | 15,183 | 234,720 | 42,467 | Dec 22, 2023, 06:26 PM |
Kanesa-thasan Niranjan | Chief Medical Officer | Dec 20, 2023 | Sale | $15.46 | 11,884 | 183,692 | 223,980 | Dec 22, 2023, 06:25 PM |
Cearley Cassia | Chief Business Officer | Dec 20, 2023 | Sale | $15.46 | 7,934 | 122,637 | 130,694 | Dec 22, 2023, 06:24 PM |
Cearley Cassia | Chief Business Officer | Dec 13, 2023 | Sale | $16.01 | 8,759 | 140,190 | 131,200 | Dec 15, 2023, 07:35 PM |
Simpson Adam K. | Chief Executive Officer | Aug 01, 2023 | Option Exercise | $0.84 | 3,000 | 2,520 | 246,930 | Aug 01, 2023, 08:54 PM |
Kanesa-thasan Niranjan | Chief Medical Officer | Jul 31, 2023 | Sale | $8.86 | 3,323 | 29,447 | 235,864 | Aug 01, 2023, 08:32 PM |
Simpson Adam K. | Chief Executive Officer | Jul 31, 2023 | Sale | $8.86 | 11,788 | 104,459 | 243,930 | Aug 01, 2023, 08:30 PM |
Russo Thomas Joseph | Chief Financial Officer | Jul 31, 2023 | Sale | $8.86 | 3,066 | 27,169 | 45,620 | Aug 01, 2023, 08:28 PM |
Cearley Cassia | Chief Business Officer | Jul 31, 2023 | Sale | $8.86 | 1,888 | 16,731 | 139,959 | Aug 01, 2023, 08:24 PM |
Holtzman Douglas | Chief Scientific Officer | Jul 03, 2023 | Option Exercise | $1.04 | 16,356 | 17,010 | 306,410 | Jul 03, 2023, 07:43 PM |
Holtzman Douglas | Chief Scientific Officer | Jul 03, 2023 | Sale | $8.85 | 16,356 | 144,743 | 292,149 | Jul 03, 2023, 07:43 PM |
Cearley Cassia | Chief Business Officer | May 23, 2023 | Sale | $10.00 | 10,000 | 100,000 | 141,847 | May 25, 2023, 07:39 PM |
Holtzman Douglas | Chief Scientific Officer | Apr 03, 2023 | Option Exercise | $1.04 | 20,443 | 21,261 | 310,497 | Apr 05, 2023, 07:12 PM |
Holtzman Douglas | Chief Scientific Officer | Apr 03, 2023 | Sale | $6.09 | 20,443 | 124,407 | 290,354 | Apr 05, 2023, 07:12 PM |
Cearley Cassia | Chief Business Officer | Mar 06, 2023 | Sale | $7.75 | 5,000 | 38,737 | 151,847 | Mar 08, 2023, 05:45 PM |
Simpson Adam K. | Chief Executive Officer | Feb 15, 2023 | Option Exercise | $1.04 | 10,677 | 11,104 | 255,718 | Feb 16, 2023, 08:00 PM |
Bekiroglu Elizabeth | General Counsel & Corp. Sec. | Feb 13, 2023 | Sale | $10.69 | 5,922 | 63,322 | 103,007 | Feb 15, 2023, 08:12 PM |
Simpson Adam K. | Chief Executive Officer | Feb 13, 2023 | Sale | $10.69 | 7,506 | 80,259 | 245,041 | Feb 15, 2023, 08:09 PM |
Holtzman Douglas | Chief Scientific Officer | Feb 14, 2023 | Sale | $10.17 | 3,349 | 34,064 | 290,054 | Feb 15, 2023, 08:07 PM |
Holtzman Douglas | Chief Scientific Officer | Feb 13, 2023 | Sale | $10.69 | 1,522 | 16,274 | 293,403 | Feb 15, 2023, 08:07 PM |
Russo Thomas Joseph | Chief Financial Officer | Feb 13, 2023 | Sale | $10.69 | 1,902 | 20,337 | 48,686 | Feb 15, 2023, 08:04 PM |
Kanesa-thasan Niranjan | Chief Medical Officer | Feb 13, 2023 | Sale | $10.69 | 1,794 | 19,183 | 239,187 | Feb 15, 2023, 07:58 PM |
Cearley Cassia | Chief Business Officer | Feb 13, 2023 | Sale | $10.69 | 1,660 | 17,750 | 156,847 | Feb 15, 2023, 07:56 PM |
Cearley Cassia | Chief Business Officer | Jan 30, 2023 | Option Exercise | $0.84 | 25,102 | 21,086 | 156,840 | Jan 31, 2023, 04:19 PM |
Simpson Adam K. | Chief Executive Officer | Jan 25, 2023 | Option Exercise | $1.00 | 13,073 | 13,117 | 252,547 | Jan 27, 2023, 05:02 PM |
Simpson Adam K. | Chief Executive Officer | Dec 23, 2022 | Option Exercise | $0.84 | 14,369 | 12,070 | 239,474 | Dec 23, 2022, 07:00 PM |
Simpson Adam K. | Chief Executive Officer | Dec 21, 2022 | Sale | $8.96 | 66,764 | 598,406 | 225,105 | Dec 23, 2022, 07:00 PM |
Holtzman Douglas | Chief Scientific Officer | Dec 15, 2022 | Sale | $11.14 | 19,648 | 218,963 | 2,792 | Dec 16, 2022, 06:36 PM |
Bekiroglu Elizabeth | General Counsel & Corp. Sec. | Sep 08, 2022 | Sale | $4.87 | 1,813 | 8,835 | 108,929 | Sep 09, 2022, 06:44 PM |
Simpson Adam K. | Chief Executive Officer | Aug 02, 2022 | Sale | $6.70 | 1,904 | 12,764 | 291,869 | Aug 02, 2022, 09:47 PM |
Simpson Adam K. | Chief Executive Officer | Aug 01, 2022 | Sale | $6.64 | 7,017 | 46,575 | 293,772 | Aug 02, 2022, 09:47 PM |
Simpson Adam K. | Chief Executive Officer | Jul 29, 2022 | Sale | $7.11 | 2,456 | 17,456 | 300,789 | Aug 02, 2022, 09:47 PM |
Russo Thomas Joseph | Chief Financial Officer | Aug 02, 2022 | Sale | $6.70 | 495 | 3,318 | 48,921 | Aug 02, 2022, 09:43 PM |
Russo Thomas Joseph | Chief Financial Officer | Aug 01, 2022 | Sale | $6.64 | 1,825 | 12,113 | 49,416 | Aug 02, 2022, 09:43 PM |
Russo Thomas Joseph | Chief Financial Officer | Jul 29, 2022 | Sale | $7.11 | 639 | 4,542 | 51,241 | Aug 02, 2022, 09:43 PM |
Holtzman Douglas | Chief Scientific Officer | Aug 02, 2022 | Sale | $6.70 | 453 | 3,037 | 293,258 | Aug 02, 2022, 09:42 PM |
Holtzman Douglas | Chief Scientific Officer | Aug 01, 2022 | Sale | $6.64 | 9,337 | 61,973 | 293,711 | Aug 02, 2022, 09:42 PM |
Holtzman Douglas | Chief Scientific Officer | Jul 29, 2022 | Sale | $7.11 | 585 | 4,158 | 303,048 | Aug 02, 2022, 09:42 PM |
Richardson Charles E | SVP, Technical Operations | Aug 02, 2022 | Sale | $6.70 | 371 | 2,487 | 165,168 | Aug 02, 2022, 09:40 PM |
Richardson Charles E | SVP, Technical Operations | Aug 01, 2022 | Sale | $6.64 | 1,368 | 9,080 | 165,539 | Aug 02, 2022, 09:40 PM |
Richardson Charles E | SVP, Technical Operations | Jul 29, 2022 | Sale | $7.11 | 479 | 3,405 | 166,907 | Aug 02, 2022, 09:40 PM |
Kanesa-thasan Niranjan | Chief Medical Officer | Aug 02, 2022 | Sale | $6.70 | 543 | 3,640 | 239,314 | Aug 02, 2022, 09:37 PM |
Kanesa-thasan Niranjan | Chief Medical Officer | Aug 01, 2022 | Sale | $6.64 | 2,001 | 13,281 | 239,857 | Aug 02, 2022, 09:37 PM |
Kanesa-thasan Niranjan | Chief Medical Officer | Jul 29, 2022 | Sale | $7.11 | 701 | 4,982 | 241,858 | Aug 02, 2022, 09:37 PM |
Cearley Cassia | Chief Business Officer | Aug 02, 2022 | Sale | $6.70 | 303 | 2,031 | 131,738 | Aug 02, 2022, 09:34 PM |
Cearley Cassia | Chief Business Officer | Aug 01, 2022 | Sale | $6.64 | 1,118 | 7,421 | 132,041 | Aug 02, 2022, 09:34 PM |
Cearley Cassia | Chief Business Officer | Jul 29, 2022 | Sale | $7.11 | 391 | 2,779 | 133,159 | Aug 02, 2022, 09:34 PM |
Simpson Adam K. | Chief Executive Officer | Jul 01, 2022 | Option Exercise | $0.84 | 7,185 | 6,035 | 303,245 | Jul 06, 2022, 06:53 PM |
MCDADE MARK | Director | Apr 01, 2022 | Buy | $7.10 | 42,225 | 299,797 | 50,243 | Apr 05, 2022, 04:10 PM |
Simpson Adam K. | Chief Executive Officer | Mar 28, 2022 | Option Exercise | $0.84 | 4,789 | 4,023 | 220,482 | Mar 30, 2022, 06:42 PM |
RA CAPITAL MANAGEMENT, L.P. | Director | Mar 29, 2022 | Buy | $4.75 | 8,900 | 42,271 | 5,963,565 | Mar 30, 2022, 04:31 PM |
RA CAPITAL MANAGEMENT, L.P. | Director | Mar 28, 2022 | Buy | $4.53 | 175,318 | 794,611 | 5,953,665 | Mar 30, 2022, 04:31 PM |
Cearley Cassia | Chief Business Officer | Mar 18, 2022 | Option Exercise | $0.84 | 35,137 | 29,515 | 133,550 | Mar 22, 2022, 04:36 PM |
Cearley Cassia | Chief Business Officer | Mar 07, 2022 | Sale | $17.16 | 10,000 | 171,629 | 98,897 | Mar 09, 2022, 05:34 PM |
Richardson Charles E | SVP, Technical Operations | Feb 14, 2022 | Option Exercise | $0.86 | 72,561 | 62,188 | 167,386 | Feb 16, 2022, 05:22 PM |
Kanesa-thasan Niranjan | Chief Medical Officer | Feb 02, 2022 | Option Exercise | $0.99 | 52,752 | 52,101 | 221,408 | Feb 04, 2022, 06:25 PM |
Simpson Adam K. | Chief Executive Officer | Jan 26, 2022 | Option Exercise | $1.00 | 90,693 | 90,968 | 215,693 | Jan 28, 2022, 06:04 PM |
Cearley Cassia | Chief Business Officer | Nov 15, 2021 | Option Exercise | $0.83 | 22,598 | 18,756 | 85,491 | Nov 17, 2021, 05:13 PM |
NanoDimension III, L.P. | Former 10% Owner | Aug 02, 2021 | Buy | $15.00 | 133,334 | 2,000,010 | 2,883,329 | Aug 04, 2021, 06:20 PM |
RA CAPITAL MANAGEMENT, L.P. | Director | Aug 02, 2021 | Buy | $15.00 | 2,666,666 | 39,999,990 | 5,140,679 | Aug 04, 2021, 04:31 PM |
Gould Terry P | Director | Aug 02, 2021 | Buy | $15.00 | 133,334 | 2,000,010 | 996,169 | Aug 03, 2021, 06:56 PM |
ADAMS STREET PARTNERS LLC | Former 10% Owner | Aug 02, 2021 | Buy | $15.00 | 133,334 | 2,000,010 | 996,169 | Aug 03, 2021, 06:24 PM |
Richardson Charles E | See Remarks | Jul 30, 2021 | Option Exercise | $15.00 | 27,750 | 416,250 | 78,883 | Aug 02, 2021, 09:32 PM |
Cearley Cassia | Chief Business Officer | Jul 30, 2021 | Option Exercise | $15.00 | 27,750 | 416,250 | 62,893 | Aug 02, 2021, 09:29 PM |
Veneman Ann M | Director | Jul 30, 2021 | Option Exercise | $15.00 | 8,500 | 127,500 | 8,500 | Aug 02, 2021, 09:27 PM |
Qiming U.S. Healthcare Fund II, L.P. | Former 10% Owner | Aug 02, 2021 | Buy | $15.00 | 221,351 | 3,320,265 | 3,523,561 | Aug 02, 2021, 09:27 PM |
Holtzman Douglas | Chief Scientific Officer | Jul 30, 2021 | Option Exercise | $15.00 | 41,500 | 622,500 | 282,482 | Aug 02, 2021, 09:26 PM |
FIELDS HEIDI | Director | Jul 30, 2021 | Option Exercise | $15.00 | 8,750 | 131,250 | 8,750 | Aug 02, 2021, 09:25 PM |
Simpson Adam K. | Chief Executive Officer | Jul 30, 2021 | Option Exercise | $15.00 | 125,000 | 1,875,000 | 125,000 | Aug 02, 2021, 09:23 PM |
Kanesa-thasan Niranjan | Chief Medical Officer | Jul 30, 2021 | Option Exercise | $15.00 | 41,500 | 622,500 | 168,656 | Aug 02, 2021, 09:20 PM |
Kanesa-thasan Niranjan | Chief Medical Officer | Aug 02, 2021 | Buy | $15.00 | 6,666 | 99,990 | 6,666 | Aug 02, 2021, 09:20 PM |
Russo Thomas Joseph | Chief Financial Officer | Jul 30, 2021 | Option Exercise | $15.00 | 32,500 | 487,500 | 32,500 | Aug 02, 2021, 09:19 PM |
Sanofi | 10% Owner | Aug 02, 2021 | Buy | $15.00 | 66,667 | 1,000,005 | 3,155,169 | Aug 02, 2021, 08:34 PM |
Owner | Relationship | Date | Value($) |
Simpson Adam K. | Chief Executive Officer | 02/01/2024 | 15,600 |
Simpson Adam K. | Chief Executive Officer | 02/01/2024 | 229,386 |
Simpson Adam K. | Chief Executive Officer | 01/22/2024 | 100,979 |
Kanesa-thasan Niranjan | Chief Medical Officer | 01/04/2023 | 249,298 |
Kanesa-thasan Niranjan | Chief Medical Officer | 01/04/2023 | 1,670,460 |
Simpson Adam K. | Chief Executive Officer | 01/02/2024 | 15,600 |
Simpson Adam K. | Chief Executive Officer | 01/02/2024 | 235,087 |
Simpson Adam K. | Chief Executive Officer | 12/21/2023 | 225,085 |
Simpson Adam K. | Chief Executive Officer | 12/21/2023 | 1,389,280 |
Simpson Adam K. | Chief Executive Officer | 12/20/2023 | 961,509 |
Russo Thomas Joseph | Chief Financial Officer | 12/20/2023 | 234,720 |
Kanesa-thasan Niranjan | Chief Medical Officer | 12/20/2023 | 183,692 |
Cearley Cassia | Chief Business Officer | 12/20/2023 | 122,637 |
Cearley Cassia | Chief Business Officer | 12/13/2023 | 140,190 |
Simpson Adam K. | Chief Executive Officer | 08/01/2023 | 2,520 |
Kanesa-thasan Niranjan | Chief Medical Officer | 07/31/2023 | 29,447 |
Simpson Adam K. | Chief Executive Officer | 07/31/2023 | 104,459 |
Russo Thomas Joseph | Chief Financial Officer | 07/31/2023 | 27,169 |
Cearley Cassia | Chief Business Officer | 07/31/2023 | 16,731 |
Holtzman Douglas | Chief Scientific Officer | 07/03/2023 | 17,010 |
Holtzman Douglas | Chief Scientific Officer | 07/03/2023 | 144,743 |
Cearley Cassia | Chief Business Officer | 05/23/2023 | 100,000 |
Holtzman Douglas | Chief Scientific Officer | 04/03/2023 | 21,261 |
Holtzman Douglas | Chief Scientific Officer | 04/03/2023 | 124,407 |
Cearley Cassia | Chief Business Officer | 03/06/2023 | 38,737 |
Simpson Adam K. | Chief Executive Officer | 02/15/2023 | 11,104 |
Bekiroglu Elizabeth | General Counsel & Corp. Sec. | 02/13/2023 | 63,322 |
Simpson Adam K. | Chief Executive Officer | 02/13/2023 | 80,259 |
Holtzman Douglas | Chief Scientific Officer | 02/14/2023 | 34,064 |
Holtzman Douglas | Chief Scientific Officer | 02/13/2023 | 16,274 |
Russo Thomas Joseph | Chief Financial Officer | 02/13/2023 | 20,337 |
Kanesa-thasan Niranjan | Chief Medical Officer | 02/13/2023 | 19,183 |
Cearley Cassia | Chief Business Officer | 02/13/2023 | 17,750 |
Cearley Cassia | Chief Business Officer | 01/30/2023 | 21,086 |
Simpson Adam K. | Chief Executive Officer | 01/25/2023 | 13,117 |
Simpson Adam K. | Chief Executive Officer | 12/23/2022 | 12,070 |
Simpson Adam K. | Chief Executive Officer | 12/21/2022 | 598,406 |
Holtzman Douglas | Chief Scientific Officer | 12/15/2022 | 218,963 |
Bekiroglu Elizabeth | General Counsel & Corp. Sec. | 09/08/2022 | 8,835 |
Simpson Adam K. | Chief Executive Officer | 08/02/2022 | 12,764 |
Simpson Adam K. | Chief Executive Officer | 08/01/2022 | 46,575 |
Simpson Adam K. | Chief Executive Officer | 07/29/2022 | 17,456 |
Russo Thomas Joseph | Chief Financial Officer | 08/02/2022 | 3,318 |
Russo Thomas Joseph | Chief Financial Officer | 08/01/2022 | 12,113 |
Russo Thomas Joseph | Chief Financial Officer | 07/29/2022 | 4,542 |
Holtzman Douglas | Chief Scientific Officer | 08/02/2022 | 3,037 |
Holtzman Douglas | Chief Scientific Officer | 08/01/2022 | 61,973 |
Holtzman Douglas | Chief Scientific Officer | 07/29/2022 | 4,158 |
Richardson Charles E | SVP, Technical Operations | 08/02/2022 | 2,487 |
Richardson Charles E | SVP, Technical Operations | 08/01/2022 | 9,080 |
Richardson Charles E | SVP, Technical Operations | 07/29/2022 | 3,405 |
Kanesa-thasan Niranjan | Chief Medical Officer | 08/02/2022 | 3,640 |
Kanesa-thasan Niranjan | Chief Medical Officer | 08/01/2022 | 13,281 |
Kanesa-thasan Niranjan | Chief Medical Officer | 07/29/2022 | 4,982 |
Cearley Cassia | Chief Business Officer | 08/02/2022 | 2,031 |
Cearley Cassia | Chief Business Officer | 08/01/2022 | 7,421 |
Cearley Cassia | Chief Business Officer | 07/29/2022 | 2,779 |
Simpson Adam K. | Chief Executive Officer | 07/01/2022 | 6,035 |
MCDADE MARK | Director | 04/01/2022 | 299,797 |
Simpson Adam K. | Chief Executive Officer | 03/28/2022 | 4,023 |
RA CAPITAL MANAGEMENT, L.P. | Director | 03/29/2022 | 42,271 |
RA CAPITAL MANAGEMENT, L.P. | Director | 03/28/2022 | 794,611 |
Cearley Cassia | Chief Business Officer | 03/18/2022 | 29,515 |
Cearley Cassia | Chief Business Officer | 03/07/2022 | 171,629 |
Richardson Charles E | SVP, Technical Operations | 02/14/2022 | 62,188 |
Kanesa-thasan Niranjan | Chief Medical Officer | 02/02/2022 | 52,101 |
Simpson Adam K. | Chief Executive Officer | 01/26/2022 | 90,968 |
Cearley Cassia | Chief Business Officer | 11/15/2021 | 18,756 |
NanoDimension III, L.P. | Former 10% Owner | 08/02/2021 | 2,000,010 |
RA CAPITAL MANAGEMENT, L.P. | Director | 08/02/2021 | 39,999,990 |
Gould Terry P | Director | 08/02/2021 | 2,000,010 |
ADAMS STREET PARTNERS LLC | Former 10% Owner | 08/02/2021 | 2,000,010 |
Richardson Charles E | See Remarks | 07/30/2021 | 416,250 |
Cearley Cassia | Chief Business Officer | 07/30/2021 | 416,250 |
Veneman Ann M | Director | 07/30/2021 | 127,500 |
Qiming U.S. Healthcare Fund II, L.P. | Former 10% Owner | 08/02/2021 | 3,320,265 |
Holtzman Douglas | Chief Scientific Officer | 07/30/2021 | 622,500 |
FIELDS HEIDI | Director | 07/30/2021 | 131,250 |
Simpson Adam K. | Chief Executive Officer | 07/30/2021 | 1,875,000 |
Kanesa-thasan Niranjan | Chief Medical Officer | 07/30/2021 | 622,500 |
Kanesa-thasan Niranjan | Chief Medical Officer | 08/02/2021 | 99,990 |
Russo Thomas Joseph | Chief Financial Officer | 07/30/2021 | 487,500 |
Sanofi | 10% Owner | 08/02/2021 | 1,000,005 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 0 | 0.00000% | -100.00% | Other |
PENTWATER CAPITAL MANAGEMENT LP | 3,000,000 | 0.53% | New | Event Driven |
BlackRock Inc. | 2,467,810 | 0.00097% | -4.41% | Other |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,380,618 | 0.88% | -40.9% | Growth At A Reasonable Price, Value |
VIVO CAPITAL, LLC | 1,704,568 | 2.2% | No change | Other |
WATER ISLAND CAPITAL LLC | 876,000 | 1.41% | New | Event Driven |
GEODE CAPITAL MANAGEMENT, LLC | 709,322 | 0.00117% | 4.25% | Other |
TIG ADVISORS, LLC | 507,122 | 1% | New | Event Driven |
GABELLI FUNDS LLC | 254,257 | 0.03% | New | Event Driven, Growth, Activists |
AQR ARBITRAGE LLC | 190,269 | 0.12% | New | Event Driven |
RENAISSANCE TECHNOLOGIES LLC | 151,200 | 0.00369% | New | Other |
TUDOR INVESTMENT CORP ET AL | 100,001 | 0.01% | New | Event Driven, Other |
HARVEST MANAGEMENT LLC | 79,000 | 1.15% | New | Event Driven |
ALPS ADVISORS INC | 35,434 | 0.00439% | New | Other |
D. E. SHAW & CO., INC. | 23,715 | 0.00033% | New | Other |
BALYASNY ASSET MANAGEMENT L.P. | 15,381 | 0.00046% | New | Event Driven |
Period of Report: 09/30/2023
10-K/10-Q Filings: View